Higher concentrations of omentin were also reported in mesothelioma [21], in gastric cancer [11], and pancreatic cancer [22] and in most of those studies, increased omentin levels were independent of BMI, glucose, and lipid parameters. This evidence concerns the gene ITLN1 and mesothelioma.